Dark

IBRX
ImmunityBio, Inc. Common Stock
stock NASDAQ

At Close

Jul 14, 2025 3:59:51 PM EDT

2.91USD+3.559%(+0.10)5,684,882

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 14, 2025 9:25:30 AM EDT

2.83USD+0.712%(+0.02)126,920

After-hours

Jul 14, 2025 4:57:30 PM EDT

2.90USD-0.344%(-0.01)3,855

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

2.56B

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Aug 6, 2025 (22d)

IBRX Stats

Avg. Vol. 10 Day

6,981,175

Avg. Vol. 30 Day

9,052,642

Employees

703

Market Cap

2,555,186,084

Shares Out.

882,620,409

On/Off Exchange

43%/57%

6 Month Beta

1.44

1 Year Beta

1.52

2 Year Beta

1.73

3 Year Beta

2.07

52 Week Low

1.83

52 Week High

7.48

SMA50

2.70

SMA200

3.30

1 Week

+6.43%

1 Month

-5.70%

3 Month

+0.17%

6 Month

+24.78%

1 Year

-54.48%

2 Year

+4.14%

5 Year

-78.59%

Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.

IBRX Stock Summary

ImmunityBio, Inc. Common Stock (NASDAQ:IBRX) stock price today is $2.91, and today's volume is 5,684,882. IBRX is up 3.559% today. The 30 day average volume is 9,052,642. IBRX market cap is 2.56B with 882,620,409 shares outstanding.

.dark-mode .hL3nDP{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .hL3nDP{ color: #333333; background-color: white; border: 2px solid #333333; }IBRXImmunityBio, Inc. Common Stockstock NASDAQ

IBRX Stock Summary

IBRX
ImmunityBio, Inc. Common Stock
stock NASDAQ